한글목차

개요

dNTP(Deoxynucleotide Triphosphates) 세계 시장2024-2028

dNTP(Deoxynucleotide Triphosphates) 시장은 2023-20281년에 7,745만 달러, 예측 기간 중 CAGR은 7.26%로 성장할 것으로 예측됩니다. 이 조사 리포트는 dNTP(Deoxynucleotide Triphosphates) 시장의 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인·과제, 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

이 조사 리포트는 현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 바이오메디컬 분야에서 PCR의 부상, DNA 시퀀싱의 용도 확대, DNA 합성 절차의 증가 등이 시장을 촉진하고 있습니다.

이 조사에서는 향후 수년간 dNTP(Deoxynucleotide Triphosphates) 시장의 성장을 촉진하는 주요 이유의 하나로 RT-PCR 애플리케이션의 증가를 들고 있습니다. 또한 시퀀싱 기술의 진보 및 치료·진단 툴로서 올리고뉴클레오티드의 사용 증가는 시장의 큰 수요로 연결됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 에코시스템

제3장 시장 규모 파악

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계의 dNTP(Deoxynucleotide Triphosphates) 시장 2018-2022
• 제품 유형별 유형 부문 분석 2018-2022
• 용도별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 제품 유형별

• 시장 부문
• 비교 : 제품 유형별
• 액체 dNTP : 시장 규모와 예측 2023-2028
• 고체 dNTP : 시장 규모와 예측 2023-2028
• 시장 기회 : 제품 유형별

제7장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 조사기관 : 시장 규모와 예측 2023-2028
• 의약품 : 시장 규모와 예측 2023-2028
• 시장 기회 : 용도별

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계의 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란의 상황
• 업계의 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• biotechrabbit GmbH
• Central Glass Co. Ltd.
• Creative Biogene
• Geneaid Biotech Ltd.
• Jena Bioscience GmbH
• Maravai LifeSciences Holdings Inc.
• MCLAB
• Merck KGaA
• Meridian Bioscience Inc.
• New England Biolabs Inc.
• Promega Corp.
• SBS Genetech Co. Ltd.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Wizbiosolutions Inc.

제13장 부록

영문목차

Abstract

Global Deoxynucleotide Triphosphates DNTPS Market 2024-2028

The deoxynucleotide triphosphates DNTPS market is forecasted to grow by USD 77.45 mn during 2023-2028, accelerating at a CAGR of 7.26% during the forecast period. The report on the deoxynucleotide triphosphates DNTPS market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prominence of PCR in biomedical sector, expanding applications of DNA sequencing, and increasing DNA synthesis procedures.

Technavio's deoxynucleotide triphosphates DNTPS market is segmented as below:

By Product Type

• Liquid DNTPS
• Solid DNTPS

By Application

• Research institutions
• Pharmaceutical

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing application of RT-PCR as one of the prime reasons driving the deoxynucleotide triphosphates DNTPS market growth during the next few years. Also, advances in sequencing technologies and rising use of oligonucleotides as therapeutic and diagnostic tools will lead to sizable demand in the market.

The report on the deoxynucleotide triphosphates DNTPS market covers the following areas:

• Deoxynucleotide triphosphates DNTPS market sizing
• Deoxynucleotide triphosphates DNTPS market forecast
• Deoxynucleotide triphosphates DNTPS market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading deoxynucleotide triphosphates DNTPS market vendors that include biotechrabbit GmbH, BR Biochem Life Sciences Pvt. Ltd., Central Glass Co. Ltd., Creative Biogene, Geneaid Biotech Ltd., Hefei Huana Biomedical Technology Co. Ltd., Hzymes Biotechnology Co. Ltd., Jena Bioscience GmbH, Larova GmbH, Maravai LifeSciences Holdings Inc., MCLAB, Merck KGaA, Meridian Bioscience Inc., Promega Corp., SBS Genetech Co. Ltd., Thermo Fisher Scientific Inc., Wizbiosolutions Inc., WUHU HUAREN SCIENCE AND TECHNOLOGY CO. LTD., New England Biolabs Inc., and Takara Bio Inc.. Also, the deoxynucleotide triphosphates DNTPS market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global deoxynucleotide triphosphates (dNTPs) market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global deoxynucleotide triphosphates (dntps) market 2018 - 2022 ($ million)
• 4.2 Product Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Type Segment 2018 - 2022 ($ million)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product Type

• 6.1 Market segments
• Exhibit 30: Chart on Product Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product Type - Market share 2023-2028 (%)
• 6.2 Comparison by Product Type
• Exhibit 32: Chart on Comparison by Product Type
• Exhibit 33: Data Table on Comparison by Product Type
• 6.3 Liquid dNTPs - Market size and forecast 2023-2028
• Exhibit 34: Chart on Liquid dNTPs - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Liquid dNTPs - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Liquid dNTPs - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Liquid dNTPs - Year-over-year growth 2023-2028 (%)
• 6.4 Solid dNTPs - Market size and forecast 2023-2028
• Exhibit 38: Chart on Solid dNTPs - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Solid dNTPs - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Solid dNTPs - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Solid dNTPs - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product Type
• Exhibit 42: Market opportunity by Product Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Product Type ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 44: Chart on Application - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 46: Chart on Comparison by Application
• Exhibit 47: Data Table on Comparison by Application
• 7.3 Research institutions - Market size and forecast 2023-2028
• Exhibit 48: Chart on Research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Research institutions - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Research institutions - Year-over-year growth 2023-2028 (%)
• 7.4 Pharmaceutical - Market size and forecast 2023-2028
• Exhibit 52: Chart on Pharmaceutical - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Pharmaceutical - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Pharmaceutical - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Pharmaceutical - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Application
• Exhibit 56: Market opportunity by Application ($ million)
• Exhibit 57: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
• Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 biotechrabbit GmbH
• Exhibit 107: biotechrabbit GmbH - Overview
• Exhibit 108: biotechrabbit GmbH - Product / Service
• Exhibit 109: biotechrabbit GmbH - Key offerings
• 12.4 Central Glass Co. Ltd.
• Exhibit 110: Central Glass Co. Ltd. - Overview
• Exhibit 111: Central Glass Co. Ltd. - Business segments
• Exhibit 112: Central Glass Co. Ltd. - Key offerings
• Exhibit 113: Central Glass Co. Ltd. - Segment focus
• 12.5 Creative Biogene
• Exhibit 114: Creative Biogene - Overview
• Exhibit 115: Creative Biogene - Product / Service
• Exhibit 116: Creative Biogene - Key offerings
• 12.6 Geneaid Biotech Ltd.
• Exhibit 117: Geneaid Biotech Ltd. - Overview
• Exhibit 118: Geneaid Biotech Ltd. - Product / Service
• Exhibit 119: Geneaid Biotech Ltd. - Key offerings
• 12.7 Jena Bioscience GmbH
• Exhibit 120: Jena Bioscience GmbH - Overview
• Exhibit 121: Jena Bioscience GmbH - Product / Service
• Exhibit 122: Jena Bioscience GmbH - Key offerings
• 12.8 Maravai LifeSciences Holdings Inc.
• Exhibit 123: Maravai LifeSciences Holdings Inc. - Overview
• Exhibit 124: Maravai LifeSciences Holdings Inc. - Business segments
• Exhibit 125: Maravai LifeSciences Holdings Inc. - Key offerings
• Exhibit 126: Maravai LifeSciences Holdings Inc. - Segment focus
• 12.9 MCLAB
• Exhibit 127: MCLAB - Overview
• Exhibit 128: MCLAB - Product / Service
• Exhibit 129: MCLAB - Key offerings
• 12.10 Merck KGaA
• Exhibit 130: Merck KGaA - Overview
• Exhibit 131: Merck KGaA - Business segments
• Exhibit 132: Merck KGaA - Key news
• Exhibit 133: Merck KGaA - Key offerings
• Exhibit 134: Merck KGaA - Segment focus
• 12.11 Meridian Bioscience Inc.
• Exhibit 135: Meridian Bioscience Inc. - Overview
• Exhibit 136: Meridian Bioscience Inc. - Business segments
• Exhibit 137: Meridian Bioscience Inc. - Key offerings
• Exhibit 138: Meridian Bioscience Inc. - Segment focus
• 12.12 New England Biolabs Inc.
• Exhibit 139: New England Biolabs Inc. - Overview
• Exhibit 140: New England Biolabs Inc. - Product / Service
• Exhibit 141: New England Biolabs Inc. - Key news
• Exhibit 142: New England Biolabs Inc. - Key offerings
• 12.13 Promega Corp.
• Exhibit 143: Promega Corp. - Overview
• Exhibit 144: Promega Corp. - Product / Service
• Exhibit 145: Promega Corp. - Key offerings
• 12.14 SBS Genetech Co. Ltd.
• Exhibit 146: SBS Genetech Co. Ltd. - Overview
• Exhibit 147: SBS Genetech Co. Ltd. - Product / Service
• Exhibit 148: SBS Genetech Co. Ltd. - Key offerings
• 12.15 Takara Bio Inc.
• Exhibit 149: Takara Bio Inc. - Overview
• Exhibit 150: Takara Bio Inc. - Business segments
• Exhibit 151: Takara Bio Inc. - Key offerings
• Exhibit 152: Takara Bio Inc. - Segment focus
• 12.16 Thermo Fisher Scientific Inc.
• Exhibit 153: Thermo Fisher Scientific Inc. - Overview
• Exhibit 154: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 155: Thermo Fisher Scientific Inc. - Key news
• Exhibit 156: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 157: Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Wizbiosolutions Inc.
• Exhibit 158: Wizbiosolutions Inc. - Overview
• Exhibit 159: Wizbiosolutions Inc. - Product / Service
• Exhibit 160: Wizbiosolutions Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 161: Inclusions checklist
• Exhibit 162: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 163: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 164: Research methodology
• Exhibit 165: Validation techniques employed for market sizing
• Exhibit 166: Information sources
• 13.5 List of abbreviations
• Exhibit 167: List of abbreviations